Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection

doi:10.3748/wjg.v29.i26.4186

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3271)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1203

Figures (1-7)

248

Tables (1-2)

175

Sum=1705

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

100

Download

427

Sum=527

Publishing Process of This Article

Item

Count

Browse

166

Download

770

Sum=936

Jul 14, 2023 (publication date) through Jun 6, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 14, 2023; 29(26): 4186-4199
Published online Jul 14, 2023. doi: 10.3748/wjg.v29.i26.4186

Full Size Figure Download Figure

Figure 1 Flowchart of the study cohorts. HCC: Hepatocellular carcinoma; CT: Computed tomography; TACE: Transarterial chemoembolization; ROI: Region of interest.

Citation: Li SQ, Su LL, Xu TF, Ren LY, Chen DB, Qin WY, Yan XZ, Fan JX, Chen HS, Liao WJ. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection. World J Gastroenterol 2023; 29(26): 4186-4199
URL: https://www.wjgnet.com/1007-9327/full/v29/i26/4186.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i26.4186